(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Countdown to Earnings: AAR, Penguin Solutions, and AngioDynamics in Focus

  • January 04th, 2026
  • 109 views

Las Vegas, NV / CRWE PRESS RELEASE / January 3, 2026 - Notable companies expected to report financial results on Tuesday, January 6, are:

AAR Corp. (NYSE: AIR), an aerospace and defense services provider, is expected to announce its second-quarter fiscal 2026 figures after the close of New York Stock Exchange trading. Wall Street consensus calls for earnings per share (EPS) of $1.04 on revenue of $760.95 million. On Friday, $AIR closed at $84.45, rising $1.66 (+2.01%).

Penguin Solutions, Inc. (Nasdaq: PENG), a technology solutions company focused on advanced computing and data infrastructure, is set to deliver results for the first quarter of fiscal 2026 following the market close. Analysts project EPS of $0.45 on revenue of $345.07 million. $PENG finished Friday at $20.28, up $0.72 (+3.68%).

AngioDynamics, Inc. (Nasdaq: ANGO), a medical technology company specializing in vascular and oncology solutions, will report its second-quarter fiscal 2026 performance before the market opens. The consensus estimate points to a loss of $0.10 per share on revenue of $76.43 million. On Friday, $ANGO closed at $12.68, down $0.16 (-1.25%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13